title: Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells.
authors: Department of Clinical Research, Tumor Immunology, University of Bern, Bern, Switzerland.
authors: C
authors: C
authors: Riether
authors: Department of Clinical Research, Tumor Immunology, University of Bern, Bern, Switzerland.
authors: T
authors: T
authors: Gschwend
authors: Department of Clinical Research, Tumor Immunology, University of Bern, Bern, Switzerland.
authors: A-L
authors: AL
authors: Huguenin
authors: 1] Department of Clinical Research, Tumor Immunology, University of Bern, Bern, Switzerland [2] Institute of Pathology, University of Bern, Bern, Switzerland.
authors: C M
authors: CM
authors: Schürch
authors: 1] Department of Clinical Research, Tumor Immunology, University of Bern, Bern, Switzerland [2] Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
authors: A F
authors: AF
authors: Ochsenbein
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D017209:Apoptosis; D049109:Cell Proliferation; D064987:Cell- and Tissue-Based Therapy; D002478:Cells, Cultured; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D014411:Neoplastic Stem Cells / Q000473:pathology*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors*; D013602:T-Lymphocytes, Cytotoxic / Q000637:transplantation*
chemical_list: C491383:Pdcd1 protein, mouse; D061026:Programmed Cell Death 1 Receptor
references: Nature. 2000 Mar 9;404(6774):193-7
references: 10724173
references: Cell Death Differ. 2015 Feb;22(2):187-98
references: 24992931
references: J Exp Med. 1998 Mar 2;187(5):763-74
references: 9480986
references: Leukemia. 2007 Mar;21(3):472-9
references: 17215853
references: Blood. 2009 Aug 20;114(8):1528-36
references: 19420358
references: Am J Hematol. 2011 Jan;86(1):31-7
references: 21132730
references: Nat Rev Cancer. 2012 Apr;12(4):252-64
references: 22437870
references: Nat Rev Immunol. 2012 Apr;12(4):269-81
references: 22437939
references: Cancer Cell. 2012 Apr 17;21(4):577-92
references: 22516264
references: J Immunol. 2012 Jul 1;189(1):39-49
references: 22634623
references: Nat Rev Cancer. 2012 Aug;12(8):513-26
references: 22825216
references: PLoS One. 2013;8(1):e55818
references: 23383287
references: J Exp Med. 2013 Mar 11;210(3):605-21
references: 23401488
references: J Clin Invest. 2013 Jun;123(6):2654-62
references: 23676461
references: Stem Cells. 2014 Apr;32(4):844-51
references: 24214290
references: Blood. 1995 Sep 1;86(5):2041-50
references: 7655033